TY - JOUR JO - EuroIntervention TI - Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> Percutaneous left atrial appendage occlusion (LAAO) may be considered for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Data on device implantation sa AU - Santoro Gennaro AU - Meucci Francesco AU - Stolcova Miroslava AU - Rezzaghi Marco AU - Mori Fabio AU - Palmieri Cataldo AU - Paradossi Umberto AU - Pastormerlo Luigi Emilio AU - Rosso Gabriele AU - Berti Sergio VL - 11 IS - 10 Y1 - 19/02/2016 Y1 - 2016 DOI - 10.4244/EIJY14M10_13 SP - 1188 EP - 1194 KW - atrial fibrillation KW - left atrial appendage occlusion KW - percutaneous KW - stroke prevention PB - Europa Digital & Publishing SE - Interventions for valvular disease and heart failure UR - https://eurointervention.pcronline.com/article/percutaneous-left-atrial-appendage-occlusion-in-patients-with-non-valvular-atrial-fibrillation-implantation-and-up-to-four-years-follow-up-of-the-amplatzer-cardiac-plug SN - 1774-024X ER -